OTUD3 Inhibitors

Chemical inhibitors of OTUD3 target the enzyme's ability to cleave ubiquitin from its substrate proteins, a vital function that regulates protein degradation and signaling pathways within the cell. NSC 632839 acts by directly binding to the active site of deubiquitinating enzymes like OTUD3, which results in the inhibition of their deubiquitinating activity. Similarly, PR-619 is a broad-spectrum inhibitor that binds to OTUD3 and prevents the removal of ubiquitin chains from substrates, thereby directly inhibiting the protein's function. WP1130, a selective DUB inhibitor, also impairs OTUD3 by blocking its active site and thus its capability to disassemble ubiquitin chains from the substrates it acts upon.

HBX 41,108, another USP7 inhibitor, likely inhibits OTUD3 by occupying its catalytic domain, which in turn obstructs its functional cycle of deubiquitination. ML323, known for its potent inhibition of the USP1/UAF1 complex, could similarly bind to the active site of OTUD3 and interfere with its deubiquitinating process. P22077 and LDN-57444, inhibitors of USP7 and UCHL1 respectively, can inhibit OTUD3 by analogous mechanisms-direct active site binding that impedes OTUD3's ability to cleave ubiquitin from its substrates. Furthermore, b-AP15 and IU1, both inhibitors of proteasomal DUBs such as UCHL5 and USP14, can inhibit OTUD3 through similar obstruction of its deubiquitinating activity. SJB2-043 and SJB3-019A, which inhibit the USP1/UAF1 complex, are also capable of inhibiting OTUD3 by directly inhibiting its enzymatic function. These inhibitors bind to the active site of OTUD3, thereby preventing the hydrolysis of the isopeptide bond between ubiquitin and lysine residues on substrate proteins, which is essential for the deubiquitination process that OTUD3 catalyzes.